ADAPTIVE BIOTECHNOLOGIES CORPORATION Interest and Other Income
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Interest and Other Income of $2.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for the quarter ending 2026-06-30 was $2.26M, a 5.65% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for the quarter ending 2026-03-31 was $2.08M, a 22.36% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for the quarter ending 2025-12-31 was $2.15M, a 30.08% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for the quarter ending 2025-09-30 was $2.23M, a 35.92% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for fiscal 2025 was $9.44M, a 35.02% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for fiscal 2024 was $14.53M, a 6.42% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for fiscal 2023 was $15.53M, a 282.91% increase from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION interest and other income for fiscal 2022 was $4.06M, a 143.17% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.26M 10-Q · filed 2026-08-04 | $4.34M 10-Q · filed 2026-08-04 | $6.48M derived: sum of 3 quarters · filed 2026-08-04 | $8.71M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.08M 10-Q · filed 2026-05-05 | $4.23M derived: sum of 2 quarters · filed 2026-05-05 | $6.45M derived: sum of 3 quarters · filed 2026-05-05 | $8.85M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.37M derived: sum of 2 quarters · filed 2026-02-26 | $6.76M derived: sum of 3 quarters · filed 2026-08-04 | $9.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.23M 10-Q · filed 2025-11-05 | $4.62M derived: sum of 2 quarters · filed 2026-08-04 | $7.30M 10-Q · filed 2025-11-05 | $10.37M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.39M 10-Q · filed 2026-08-04 | $5.07M 10-Q · filed 2026-08-04 | $8.14M derived: sum of 3 quarters · filed 2026-08-04 | $11.62M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.68M 10-Q · filed 2026-05-05 | $5.75M derived: sum of 2 quarters · filed 2026-05-05 | $9.22M derived: sum of 3 quarters · filed 2026-05-05 | $12.99M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.55M derived: sum of 2 quarters · filed 2026-02-26 | $10.31M derived: sum of 3 quarters · filed 2026-02-26 | $14.53M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.47M 10-Q · filed 2025-11-05 | $7.24M derived: sum of 2 quarters · filed 2025-11-05 | $11.46M 10-Q · filed 2025-11-05 | $16.07M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.77M 10-Q · filed 2025-08-05 | $7.99M 10-Q · filed 2025-08-05 | $12.60M derived: sum of 3 quarters · filed 2026-02-26 | $16.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.22M 10-Q · filed 2025-05-01 | $8.84M derived: sum of 2 quarters · filed 2026-02-26 | $13.12M derived: sum of 3 quarters · filed 2026-02-26 | $16.73M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.89M derived: sum of 2 quarters · filed 2026-02-26 | $12.51M derived: sum of 3 quarters · filed 2026-02-26 | $15.53M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.28M 10-Q · filed 2024-11-07 | $7.89M derived: sum of 2 quarters · filed 2024-11-07 | $10.92M 10-Q · filed 2024-11-07 | $13.52M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $3.61M 10-Q · filed 2024-08-01 | $6.64M 10-Q · filed 2024-08-01 | $9.24M derived: sum of 3 quarters · filed 2025-03-03 | $10.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $3.02M 10-Q · filed 2024-05-07 | $5.63M derived: sum of 2 quarters · filed 2025-03-03 | $6.39M derived: sum of 3 quarters · filed 2025-03-03 | $6.81M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.37M derived: sum of 2 quarters · filed 2025-03-03 | $3.79M derived: sum of 3 quarters · filed 2025-03-03 | $4.06M 10-K · filed 2025-03-03 |
| 2022-09-30 | $765.00K 10-Q · filed 2023-11-09 | $1.18M derived: sum of 2 quarters · filed 2023-11-09 | $1.45M 10-Q · filed 2023-11-09 | $1.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $418.00K 10-Q · filed 2023-08-02 | $689.00K 10-Q · filed 2023-08-02 | $928.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.25M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $271.00K 10-Q · filed 2023-05-03 | $510.00K derived: sum of 2 quarters · filed 2024-02-29 | $837.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.30M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $566.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.03M derived: sum of 3 quarters · filed 2024-02-29 | $1.67M 10-K · filed 2024-02-29 |
| 2021-09-30 | $327.00K 10-Q · filed 2022-11-03 | $791.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.43M 10-Q · filed 2022-11-03 | $2.21M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $464.00K 10-Q · filed 2022-08-03 | $1.10M 10-Q · filed 2022-08-03 | $1.89M derived: sum of 3 quarters · filed 2023-02-14 | $2.90M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $638.00K 10-Q · filed 2022-05-04 | $1.42M derived: sum of 2 quarters · filed 2023-02-14 | $2.44M derived: sum of 3 quarters · filed 2023-02-14 | $4.33M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $1.80M derived: sum of 2 quarters · filed 2023-02-14 | $3.70M derived: sum of 3 quarters · filed 2023-02-14 | $6.59M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.02M 10-Q · filed 2021-11-03 | $2.91M derived: sum of 2 quarters · filed 2021-11-03 | $5.80M 10-Q · filed 2021-11-03 | $9.38M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $1.89M 10-Q · filed 2021-08-04 | $4.79M 10-Q · filed 2021-08-04 | $8.36M derived: sum of 3 quarters · filed 2022-02-15 | $12.47M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.89M 10-Q · filed 2021-05-05 | $6.47M derived: sum of 2 quarters · filed 2022-02-15 | $10.57M derived: sum of 3 quarters · filed 2022-02-15 | $11.02M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $7.68M derived: sum of 2 quarters · filed 2022-02-15 | $8.13M derived: sum of 3 quarters · filed 2022-02-15 | $9.79M 10-K · filed 2022-02-15 |
| 2019-09-30 | $4.10M 10-Q · filed 2020-11-10 | $4.55M derived: sum of 2 quarters · filed 2020-11-10 | $6.21M 10-Q · filed 2020-11-10 | $7.08M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $446.00K 10-Q · filed 2020-08-10 | $2.10M 10-Q · filed 2020-08-10 | $2.98M derived: sum of 3 quarters · filed 2021-02-24 | $3.85M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.66M 10-Q · filed 2020-05-12 | $2.53M derived: sum of 2 quarters · filed 2021-02-24 | $3.40M derived: sum of 3 quarters · filed 2021-02-24 | $4.22M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.74M derived: sum of 2 quarters · filed 2021-02-24 | $2.56M derived: sum of 3 quarters · filed 2021-02-24 | $3.31M 10-K · filed 2021-02-24 |
| 2018-09-30 | $869.00K 10-Q · filed 2019-11-12 | $1.69M derived: sum of 2 quarters · filed 2019-11-12 | $2.44M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $820.00K 10-Q · filed 2019-08-13 | $1.57M 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $1.64M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |